Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-...
Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy
About this item
Full title
Author / Creator
Silverberg, Jonathan I. , Bieber, Thomas , Paller, Amy S. , Beck, Lisa , Kamata, Masahiro , Puig, Luis , Wiseman, Marni , Ezzedine, Khaled , Irvine, Alan D. , Foley, Peter , Del Rosso, James , Gold, Linda Stein , Johansson, Erin , Dossenbach, Martin , Gallo, Gaia , Akmaz, Buelent , Casillas, Marta , Karlsson, Andrei , Curteis, Tristan and Chovatiya, Raj
Publisher
Cheshire: Springer Healthcare
Journal title
Language
English
Formats
Publication information
Publisher
Cheshire: Springer Healthcare
Subjects
More information
Scope and Contents
Contents
Introduction
A systematic literature review and network meta-analysis (NMA) were conducted to compare the short-term efficacy of lebrikizumab to other biologic and Janus kinase (JAK) inhibitor monotherapies approved for moderate-to-severe atopic dermatitis in adults and adolescents.
Methods
The NMA included randomized, double-blind, placeb...
Alternative Titles
Full title
Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy
Authors, Artists and Contributors
Author / Creator
Bieber, Thomas
Paller, Amy S.
Beck, Lisa
Kamata, Masahiro
Puig, Luis
Wiseman, Marni
Ezzedine, Khaled
Irvine, Alan D.
Foley, Peter
Del Rosso, James
Gold, Linda Stein
Johansson, Erin
Dossenbach, Martin
Gallo, Gaia
Akmaz, Buelent
Casillas, Marta
Karlsson, Andrei
Curteis, Tristan
Chovatiya, Raj
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4bb3e2bcebc647b0b983358f1063ff3d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4bb3e2bcebc647b0b983358f1063ff3d
Other Identifiers
ISSN
2193-8210
E-ISSN
2190-9172,2193-8210
DOI
10.1007/s13555-025-01357-7
